An effort to bring state oversight to an unregulated sector of the pharmaceutical industry is off the table for the fall legislative session. Capital Public Radio's Sammy Caiola explains why.
Calif. Bill To Provide Transparency In Negotiated Drug Prices Stalls For The Year
chieforganizer.org
